MO BIO IS NOW A QIAGEN COMPANY
MO BIO Laboratories was founded in 1993 by Liz and Mark Brolaski. On November 20, 2015, QIAGEN acquired MO BIO Laboratories. On January 1, 2017, MO BIO was fully integrated with QIAGEN. MO BIO's popular DNA and RNA isolation kits are now part of QIAGEN's sample preparation portfolio.
QIAGEN is the leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. The company’s portfolio consists of more than 500 core products, which can be classified into three categories:
- Consumables: Ready-to-use reagent kits and individual components for a broad range of applications from the processing of samples to detection of various molecular targets such as DNA or RNA.
- Instruments: Individual instruments, as well as combined platforms for automation of laboratory workflows, ensuring highly accurate and reliable processing of samples and analysis of molecular targets.
- Bioinformatics: Software solutions and knowledge bases for processing large volumes of complex biological data, interpreting the information and reporting relevant, actionable insights – primarily in clinical and research applications of next-generation sequencing.